ETX.L Regulatory News (ETX)

e-Therapeutics plc

('e-Therapeutics' or 'the Company')

Issue of equity

6 August 2013, Oxford and Newcastle, UK: e-Therapeutics plc (AIM: ETX), the drug discovery and development company, announces that the Company has today issued 175,000 ordinary shares of 0.1p each in the Company in order to satisfy the exercise of certain options by a former employee.

Application has been made to admit the new ordinary shares to trading on AIM and dealings in the new ordinary shares are expected to commence on 12 August 2013. Following admission the number of Ordinary Shares in the Company in issue will be 263,766,443. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, e-Therapeutics plc under the Financial Conduct Authority's Disclosure and Transparency Rules.

Contacts:

e-Therapeutics plc

Daniel Elger

Tel: +44 (0) 7909 915 068

www.etherapeutics.co.uk 

Panmure Gordon (UK) Limited

Corporate Finance: Fred Walsh / Grishma Patel

Corporate Broking: Hannah Woodley

Tel: +44 (0) 20 7886 2500

www.panmure.com